Astellas Pharma Inc. ADR (ALPMY)
Market Closed
15 Oct, 08:00 PM
OTC PINK OTC PINK Primary 
XFRA $
14. 98
+0.63
+4.3902%
$
25.73B Market Cap
- P/E Ratio
0.88% Div Yield
27,004 Volume
- Eps
$ 14.35
Previous Close Want to track ALPMY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Are Investors Undervaluing Astellas Pharma (ALPMY) Right Now?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks | 2 years ago
Japan's Astellas says employee indicted by China's prosecutors
Chinese authorities have indicted a Japanese employee of Astellas Pharma Inc , who had been detained in China since March 2023 on suspicion of espionage, the Japanese pharmaceutical company said on Wednesday.
Reuters | 2 years ago
UK regulator approves Astellas' gastric cancer drug
Britain's health regulator said on Wednesday it has approved Astellas Pharma's drug to treat a type of gastric cancer.
Reuters | 2 years ago
2026 © Marketlog. All Rights Reserved.
